SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,003.82 -777.94
( -1.04%)

Global Indices

Nasdaq

52,102.03 -340.17
(-0.65%)

Dow Jones

7,605.54 -35.44
(-0.46%)

Hang Seng

63,634.18 141.19
(0.22%)

Nikkei 225

10,654.59 -42.98
(-0.40%)

Forex

USD-INR

95.47 0.03
(0.03%)

EUR-INR

110.72 -0.23
(-0.20%)

GBP-INR

129.12 -0.04
(-0.03%)

JPY-INR

0.62 0.00
(0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533573

INE901L01018

285.6722314

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

APLLTD

20.52

16193.85

EPS(TTM)

Face Value()

Div & Yield %

40.14

1.46

Back

JTEKT India standalone net profit declines 42.51% in the June 2026 quarter

Aug 13,2026

Net profit of JTEKT India declined 42.51% to Rs 6.22 crore in the quarter ended June 2026 as against Rs 10.82 crore during the previous quarter ended June 2025. Sales rose 26.85% to Rs 717.98 crore in the quarter ended June 2026 as against Rs 566.02 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	717.98	566.02	27
OPM %	5.32	5.45	-
PBDT	36.93	35.54	4
PBT	8.62	14.55	-41
NP	6.22	10.82	-43

74,003.82 -777.94 ( -1.04%)

52,102.03 -340.17 (-0.65%)

7,605.54 -35.44 (-0.46%)

63,634.18 141.19 (0.22%)

10,654.59 -42.98 (-0.40%)

95.47 0.03 (0.03%)

110.72 -0.23 (-0.20%)

129.12 -0.04 (-0.03%)

0.62 0.00 (0.29%)